Investment
Features
FeesSafety
Academy
More
Pluang+

Compare HSBC Holdings plc (HSBC) vs Immunovant Inc. Common Stock (IMVT) Price & Performance

HSBC Holdings plcTrade
Immunovant Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

HSBC Holdings plc vs Immunovant Inc. Common Stock — how do they compare? HSBC Holdings plc trades at $92.89 (market cap $311.92B), while Immunovant Inc. Common Stock trades at $30.41 (market cap $6.25B). The key difference: HSBC Holdings plc is far larger — about 49.9× Immunovant Inc. Common Stock's market cap, and HSBC Holdings plc pays a 4.05% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold HSBC Holdings plc for 36 Days and Immunovant Inc. Common Stock for 1 Days on average.

HSBCIMVT
Market Cap
$311.92B$6.25B
Volume
3,546,6581,755,411
Sector
FinancialsHealth
52-Week High
$107.86$44.96
52-Week Low
$65.67$17.03
Typical Hold Time
36 Days1 Days
Enterprise Value
$222.19B$5.35B
Dividend Yield
4.05%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

HSBC Holdings plc

HSBC trades at $92.80, down 0.97% with bearish technical signals. The stock shows strong profitability with 34.54% net margin and reasonable valuation at 13.23 P/E. Recent earnings were mixed with Q2 beat but Q1 miss. Analyst sentiment is cautious with 38% buy ratings. The bank is expanding in technology banking and US wealth services while restructuring European operations.

HSBC offers value with solid fundamentals but faces near-term headwinds from technical weakness and mixed earnings performance. Growth opportunities in Asian markets and wealth management balance risks from European restructuring and CFO transition in 2027.

Immunovant Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HSBC
62% Buy38% Sell
Avg holding period · 36 Days
IMVT

No sentiment data available yet.

About HSBC Holdings plc

HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.

Read more on HSBC →

About Immunovant Inc. Common Stock

Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.

Read more on IMVT →